These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 37143723)

  • 1. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.
    Partenope C; Pedranzini Q; Petri A; Rabbone I; Prodam F; Bellone S
    Front Endocrinol (Lausanne); 2023; 14():1166953. PubMed ID: 37143723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient Central Diabetes Insipidus (Arginine Vasopressin Deficiency) Following SARS-CoV-2 Vaccination: A Case Report and Literature Review.
    Mazzeo P; Ceccato F; Manara R; Mazzon C; Barbot M
    Endocr Metab Immune Disord Drug Targets; 2024; 24(15):1856-1864. PubMed ID: 38243973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report.
    Bouça B; Roldão M; Bogalho P; Cerqueira L; Silva-Nunes J
    Front Endocrinol (Lausanne); 2022; 13():889074. PubMed ID: 35600593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
    Ishay A; Shacham EC
    BMC Endocr Disord; 2023 Feb; 23(1):47. PubMed ID: 36810011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central diabetes insipidus secondary to COVID-19 infection: a case report.
    Yavari A; Sharifan Z; Larijani B; Mosadegh Khah A
    BMC Endocr Disord; 2022 May; 22(1):134. PubMed ID: 35590312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral Optic Neuritis and Hypophysitis With Diabetes Insipidus 1 Month After COVID-19 mRNA Vaccine: Case Report and Literature Review.
    Matsuo T; Okubo K; Mifune H; Imao T
    J Investig Med High Impact Case Rep; 2023; 11():23247096231186046. PubMed ID: 37431875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy.
    Sakurai K; Yamashita R; Niituma S; Iwama S; Sugimura Y; Arihara Z; Takahashi K
    Endocr J; 2017 Jun; 64(6):645-650. PubMed ID: 28420857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated Langerhans cell histiocytosis in the hypothalamic-pituitary region: a case report.
    Zhou W; Rao J; Li C
    BMC Endocr Disord; 2019 Dec; 19(1):143. PubMed ID: 31856773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocytic infundibulo-hypophysitis with diabetes insipidus as a new clinical entity: a case report and review of the literature].
    Miyagi K; Shingaki T; Ito K; Koga H; Mekaru S; Kinjo T; Arakaki Y; Nakasone S
    No Shinkei Geka; 1997 Feb; 25(2):169-75. PubMed ID: 9027895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Diabetes Insipidus Due to IgG4-related Hypophysitis That Required over One Year to Reach the Final Diagnosis Due to Symptoms Being Masked by Sialadenitis.
    Iwamoto Y; Mori S; Tatsumi F; Sugisaki T; Dan K; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Mune T; Kaneto H
    Intern Med; 2022 Dec; 61(23):3541-3545. PubMed ID: 35569983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When polyuria does not stop: a case report on an unusual complication of hantavirus infection.
    Schwab S; Lissmann S; Schäfer N; Isaak A; Klingmüller D; Attenberger U; Eis-Hübinger AM; Hofmann J; Strassburg CP; Lutz P
    BMC Infect Dis; 2020 Sep; 20(1):713. PubMed ID: 32993515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central diabetes insipidus with anti-rabphilin-3A antibody positivity causing hypovolemic shock after resection of tumorous lesions in the pelvic cavity.
    Ohashi A; Takeda Y; Watada M; Ihara F; Oshita T; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Maeda Y
    CEN Case Rep; 2023 Aug; 12(3):297-303. PubMed ID: 36574196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rare Case of Familial Neurogenic Diabetes Insipidus in a 22-Year-Old Man.
    Phan VTT; Bloomer ZW; Phan VTX; Shakir MKM; Hoang TD
    AACE Clin Case Rep; 2021; 7(6):338-341. PubMed ID: 34765727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiuretic hormone deficiency secondary to inactive hydrocephalus: a case report.
    Kadel A; Kharal N; Sapkota S; Pokhrel P; Sharma AK; Bhattarai A; Raut M; Dubey RK; Tuladhar ET; Sharma VK; Niraula A
    J Med Case Rep; 2024 Mar; 18(1):133. PubMed ID: 38555457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central diabetes insipidus caused by a pituitary stalk germinoma resembling infundibuloneurohypophysitis.
    Dias D; Vilar H; Passos J; Leite V
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32912882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypopituitarism with secondary adrenocortical insufficiency and arginine vasopressin deficiency due to hypophysitis after COVID-19 vaccination: a case report.
    Watanabe S; Tamura Y; Oba K; Kitayama S; Sato M; Kodera R; Toyoshima K; Chiba Y; Araki A
    BMC Endocr Disord; 2024 May; 24(1):71. PubMed ID: 38769570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Hypophysitis Associated With SARS-CoV-2 Vaccination.
    Ankireddypalli AR; Chow LS; Radulescu A; Kawakami Y; Araki T
    AACE Clin Case Rep; 2022; 8(5):204-209. PubMed ID: 35754921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of central diabetes insipidus after COVID-19 as a probable diagnosis of lymphocytic infundibulo-neurohypophysitis with positive anti-rabphilin-3A antibodies with review of literature.
    Natsuki Y; Nagata Y; Nagasaki T; Morimoto M; Toi N; Kurajoh M; Morioka T; Shoji T; Imanishi Y; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Emoto M
    Endocr J; 2024 Aug; ():. PubMed ID: 39198191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'If there were water we should stop and drink': neurofibromatosis presenting with diabetes insipidus.
    Barry R; O' Connor A; Awang MH; O' Toole O
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29440241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy.
    Deligiorgi MV; Siasos G; Vergadis C; Trafalis DT
    Int Immunopharmacol; 2020 Jun; 83():106427. PubMed ID: 32244049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.